Media headlines about Analogic (NASDAQ:ALOG) have been trending somewhat positive on Saturday, according to Accern. Accern ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Analogic earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned headlines about the medical research company an impact score of 46.4282066928772 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Analogic (NASDAQ:ALOG) traded up $0.85 on Friday, reaching $78.90. 129,202 shares of the company’s stock traded hands, compared to its average volume of 85,585. The firm has a market capitalization of $974.43, a price-to-earnings ratio of -13.79, a PEG ratio of 3.90 and a beta of 0.82. Analogic has a 12 month low of $66.00 and a 12 month high of $89.50.

Analogic (NASDAQ:ALOG) last posted its earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.32. The company had revenue of $106.90 million for the quarter, compared to analyst estimates of $100.55 million. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The business’s revenue for the quarter was down 11.7% compared to the same quarter last year. During the same period last year, the business posted $0.43 earnings per share. equities research analysts expect that Analogic will post 2.86 earnings per share for the current year.

ALOG has been the topic of a number of recent research reports. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Friday, December 8th. Jefferies Group reaffirmed a “hold” rating and issued a $80.00 price objective on shares of Analogic in a research note on Friday, December 8th. Finally, BidaskClub cut shares of Analogic from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Analogic (ALOG) Share Price” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.dailypolitical.com/2018/02/10/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-analogic-alog-share-price.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Insider Buying and Selling by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.